C21 Reports Q2 Revenue Up 14% QoQ, South Reno Cannabis Dispensary Sees 53% Sales Growth
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Nov 15 2024
0mins
Source: Benzinga
Financial Performance: C21 Investments Inc. reported a revenue of $7.5 million for Q2 2024, marking a 14% increase from the previous quarter, with gross margins rising to 43.5% and positive adjusted EBITDA of $1.3 million.
Dispensary Success: The new South Reno dispensary saw a significant sales increase of 53% in its first quarter, generating $416,000 in September and continuing to grow with $475,000 in October.
Discover Tomorrow's Bullish Stocks Today
Receive free daily stock recommendations and professional analysis to optimize your portfolio's potential.
Sign up now to unlock expert insights and stay one step ahead of the market trends.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
